Synthesis:
General. All chemicals were purchased from Sigma-Aldrich or Alfa Aesar unless otherwise stated and were used without further purification. DOTAGA(tBu) 4 was synthesized as reported in the literature. [1] 1 H and 13 C NMR spectra were recorded on Bruker Avance III or on JEOL ECP 400 spectrometers operating at 11.74 T and 9.4 T, respectively. Chemical shifts are reported relative to TMS and were referenced using the residual proton solvent resonances. Electrospray ionization mass spectra (ESI MS) were recorded on a SQD 3100
Mass Detector (Waters), operating in positive or negative ion mode, with 1% v/v formic acid in methanol as the carrier solvent. ESI MS spectra on Gd-complex was acquired on a high resolving power mass spectrometer LTQ Orbitrap (Thermo Scientific, Rodano, Italy), equipped with an atmospheric pressure interface and an ESI ion source. Elemental analyses were carried out with a EA3000 CHN Elemental Analyzer (EuroVector, Milano, Italy) . 
DOTAGA(tBu) 4 NHS
DOTAGA(tBu) 4 (530 mg; 0.76 mmol) and EDC (217 mg; 1.13 mmol) were dissolved in 10 ml of dichloromethane under N 2 . N-hydroxysuccinimide (217 mg; 1.13 mmol) was added in portion and the mixture was stirred for 4 hours at room temperature. Then the organic phase was washed with water (2 x 10 mL) and brine (2 x 10 mL) and dried over Na 2 dissolved in 5 ml of pyridine under N 2 , and the mixture was stirred for 24 hours at a constant temperature of 70 °C. Then, the solvent was removed by evaporation under vacuum. The crude was dissolved in dichloromethane (10 mL) and washed with water (2 x 10 mL) and brine (2 x 10 mL).
The organic phase was then dried over Na 2 SO 4 , filtered and evaporated to obtain a white solid (451 mg, 0.37 mmol, 85% yield 
Nanosystems

Nanosystem preparation
Nanosystems were prepared by the thin film hydration method. [2] Briefly, appropriate amounts of amphiphilic material (phospholipids for liposomes, and Janus Dendrimers "JDs" for dendrimersomes), DSPE-PEG2000-COOH, and the amphiphilic complexes Gd-GOTAGA(C 18 ) 2 or
Gd-GOTAMA(C 18 ) 2 , were weighted and dissolved into chloroform. For dendrimersome preparation, the JD 3,5-C12-EG-(OH) 4 was used to create the vesicles. [3] The vesicular membrane composition was envisaged to contain phospholipids or JDs, DSPE-PEG2000-COOH and the paramagnetic complexes always in the following molar ratio: 75:5:20. After dissolution, the organic solvent was slowly removed by means of a rotary evaporator, so that the amphiphilic components were distributed in a thin homogeneous film. After two hours under vacuum, film hydration was performed at 50°C. Amphiphilic films were hydrated with a 300 mOsm HEPES-buffered solution at 
Cell viability
Cells
All cell lines were obtained from American Type Culture Collection (ATCC, Manassass, VA, USA) and resulted negative for mycoplasma test (MycoAlert TM Mycoplasma Detection Kit, Lonza
Sales AG, Verviers, Belgium). Murine fibroblasts (NIH/3T3), melanoma (B16.F10) and human umbilical vein endothelial (HUVEC) cells were cultured as monolayers at 37°C in a 5% CO 2 -containing humidified atmosphere in Dulbecco's modified Eagle's medium (DMEM). The medium was supplemented with 10% (v/v) of heat-inactivated fetal bovine serum, 2 mM of Glutamine, 100 U/ml of penicillin and 100 μg/ml of streptomycin. At 80% confluency, cells were trypsinized with 0.01% trypsin and 0.02% EDTA in Phosphate-buffered Saline (PBS). All cells employed for cellular tests were at passages included between 5 and 10. Culture medium, fetal bovine serum, penicillin-streptomycin mixture and trypsin were all purchased from Lonza (Lonza Sales AG, Verviers, Belgium).
Cell incubation and viability assessment
The cell viability was assessed on murine fibroblasts (NIH/3T3), melanoma (B16. 
In vivo experiments
To confirm in vitro data, the in vivo performance of the Gd-DOTAGA(C 18 ) 2 complex was investigated on experimental tumour models by an MRI scanner operating at 1 T (40 MHz). Among the previously studied nanosystems, dendrimersomes (DS) were selected to perform the in vivo experiments: vesicular suspensions loaded with the new Gd-agent were systemically administered to mice bearing subcutaneous syngeneic B16 melanomas (0.05 mmol Gd kg -1 body weight) and compared to analogous DS bearing the same percentage of Gd-DOTAMA(C 18 ) 2 .
Cells
Melanoma cells (B16-F10) were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and resulted negative for mycoplasma test (MycoAlert TM Mycoplasma Detection Kit, Lonza Sales AG, Verviers, Belgium). Cells were cultured as monolayers at 37°C in a 5% CO 2 -containing humidified atmosphere in Dulbecco's modified Eagle's medium (DMEM). The medium was supplemented with 10% (v/v) of heat-inactivated fetal bovine serum, 2 mM of Glutamine, 100 U/ml of penicillin and 100 μg/ml of streptomycin. At 80% confluency, cells were 10 detached with 0.01% trypsin and 0.02% EDTA in PBS. Culture medium, fetal bovine serum, penicillin-streptomycin mixture and trypsin were all purchased from Lonza (Lonza Sales AG, Verviers, Belgium).
Animals
Female C57/BL6 mice with same age (8 weeks) and similar weight (around 20-22 g) were used for the in vivo experiments, with at least three animals per condition in all performed experiments. All mice involved in the study were obtained from Charles River Laboratories (Calco, LC, Italy) and maintained in standard housing conditions, with water and rodent chow ad libitum and 12 h light/dark cycle. Animal manipulation and all experimental procedures were performed in accordance with the European Community guidelines and approved by the Ethical Committee of the University of Torino.
In vivo MRI
The performance of the two Gd-complexes (Gd-DOTAGA(C 18 ) 2 or Gd-DOTAMA(C 18 ) 2 ) was investigated in xenograft mouse models bearing a melanoma B16 syngeneic tumour. Gd-complexes were incorporated into the membrane of the DSs, as described above. Tumours were generated by subcutaneous injection of 2. The mean Signal Intensity (SI 0 ) was calculated on the manually drawn ROIs on T 1 -weighted (T 1w ) images. To take into accounts differences among images due to the animal repositioning in the MRI scanner, the SI 0 was normalized with respect to an external reference (0.5 mM of Gadoteridol aqueous solution, ProHance® (Gd-HPDO3A) provided by Bracco Imaging, Milan, Italy) to obtain the normalized Signal Intensity, SI n .
The percentage T 1 contrast enhancement (T 1 -CE) was calculated with respect to the signal measured before the injection of vesicles (SI nPRE ), by applying the following expression:
12 Figure S4 . Time evolution of the percentage T 1 contrast enhancement (T 1 -CE) calculated on T 1w
images of kidneys after the systemic administration of GdDOTAGA(C 18 ) 2 or GdDOTAMA(C 18 ) 2 -loaded dendrimersomes (black squares and white squares, respectively). 
Biodistribution
After 6 h or 14 days from the injection, animals were sacrificed to obtain the organs (kidneys, liver, spleen, and tumour), and the content of Gd 3+ was quantified by ICP-MS measurement after digestion. Briefly, the weights of all organs were accurately registered. Then, the biological 
